In this study, we present genetically engineered mice with targeted knock-in of human cancer-associated FOXA1 mutant transgenes, which provide crucial mechanistic insights into the divergent mechanisms of FOXA1 Class 1 and Class 2 alterations in PCa formation and progression. The gene discussed is FOXA1; the disease is posterior cortical atrophy.